Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011
Cash Flows from Operating Activities:
Net income/(loss) including income attributable to noncontrolling interest	$ 1,624		$ 580
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Depreciation, amortization, and accretion	567		563
Origination of Mortgage Servicing Rights (MSRs)	(244)		(183)
Provisions for credit losses and foreclosed property	1,191		1,309
Mortgage repurchase provision	701		287
Net (gain)/loss on extinguishment of debt	(15)		3
Gain (Loss) on Sale of Securities, Net	(1,973)	[1]	(98)	[1]
Net gain on sale of assets	(865)		(309)
Net decrease/(increase) in loans held for sale	(199)		2,146
Net (increase)/decrease in other assets	457		(556)
Net increase/(decrease) in other liabilities	(313)		0
Net cash provided by operating activities	946		3,739
Cash Flows from Investing Activities:
Proceeds from maturities, calls, and paydowns of securities available for sale	5,431		3,903
Proceeds from sales of securities available for sale	4,195		11,585
Purchases of securities available for sale	(3,097)		(15,664)
Proceeds from maturities, calls, and paydowns of trading securities	0		132
Proceeds from sales of trading securities	0		102
Net (increase)/decrease in loans including purchases of loans	(4,833)		(5,018)
Proceeds from sales of loans	2,041		499
Capital expenditures	(168)		(78)
Contingent consideration and other payments related to acquisitions	(13)		(20)
Proceeds from the sale of other assets	363		481
Net cash (used in)/provided by investing activities	3,919		(4,078)
Cash Flows from Financing Activities:
Net (decrease)/increase in total deposits	(696)		3,207
Net increase/(decrease) in funds purchased, securities sold under agreements to repurchase, and other short-term borrowings	(2,645)		1,416
Proceeds from the issuance of long-term debt	4,000		1,039
Repayment of long-term debt	(4,359)		(1,255)
Proceeds from the issuance of common stock	0		1,017
Repurchase of preferred stock	0		(4,850)
Purchase of outstanding warrants	0		(11)
Common and preferred dividends paid	(89)		(102)
Proceeds from (Payments for) Other Financing Activities	22		0
Net cash provided by/(used in) financing activities	(3,767)		461
Net (decrease)/increase in cash and cash equivalents	1,098		122
Cash and cash equivalents at beginning of period	4,509		5,378
Cash and cash equivalents at end of period	5,607		5,500
Supplemental Disclosures:
Loans transferred from loans held for sale to loans	34		53
Loans transferred from loans to loans held for sale	3,112		657
Loans transferred from loans and loans held for sale to other real estate owned	304		570
Accretion of discount for preferred stock issued to the U.S. Treasury	$ 0		$ 80

[1] Includes credit-related OTTI losses of $3 million and $7 million for the three and nine months ended September 30, 2012, respectively, and $0 and $2 million for the three and nine months ended September 30, 2011, respectively. There were no non-credit related unrealized OTTI losses recorded in OCI, before taxes, for the three and nine months ended September 30, 2012 and 2011.